Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Quah, Cheng Sim
46  Ergebnisse:
Personensuche X
?
1

Academic Leadership Qualities Towards Innovation Endeavours..:

, In: The Palgrave Handbook of Workplace Innovation,
Quah, Cheng Sim ; Sim, Sandra Phek Lin ; Tan, Wee-Liang - p. 371-389 , 2021
Link: https://doi.org/10.1007/..
 
?
2

Online Learning: A Post Covid-19 Alternative Pedagogy For U..:

Quah, Cheng-Sim ; Sim, Hannah Phek-Khiok ; Sim, Sandra Phek-Lin
Asian Journal of University Education.  16 (2021)  4 - p. 137 , 2021
Link: https://doi.org/10.24191..
 
?
3

Intelligent entrepreneurship and firm performance: A cross-..:

Rahim, M. Afzalur ; Ma, Zhenzhong ; Quah, Cheng-Sim...
Journal of International Entrepreneurship.  17 (2019)  4 - p. 475-493 , 2019
Link: https://doi.org/10.1007/..
 
?
4

Academic leadership qualities towards innovation endeavours..:

QUAH, Cheng Sim ; SIM, Sandra Phek Lin ; TAN, Wee Liang
https://ink.library.smu.edu.sg/lkcsb_research/7482.  , 2021
Link: https://ink.library.smu...
 
?
5

A Phase I Study of KIN-3248, an Irreversible Small-molecule..:

Garmezy, Benjamin ; Borad, Mitesh J. ; Bahleda, Rastilav...
Cancer Research Communications.  4 (2024)  4 - p. 1165-1173 , 2024
Link: https://doi.org/10.1158/..
 
?
6

Treatment patterns and clinical outcomes in elderly patient..:

Kaufman, Peter A. ; Brufsky, Adam M. ; Mayer, Musa...
Breast Cancer Research and Treatment.  135 (2012)  3 - p. 875-883 , 2012
Link: https://doi.org/10.1007/..
 
?
7

Phase II study of acalabrutinib in ibrutinib-intolerant pat..:

Rogers, Kerry A. ; Thompson, Philip A. ; Allan, John N....
Haematologica.  106 (2021)  9 - p. 2364-2373 , 2021
Link: https://doi.org/10.3324/..
 
?
8

Acalabrutinib with Obinutuzumab in Treatment-Naive (TN) and..:

Woyach, Jennifer A. ; Rogers, Kerry A. ; Bhat, Seema...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  - p. S281 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Pati..:

Rogers, Kerry A. ; Thompson, Philip A. ; Allan, John N....
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  - p. S282-S283 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Acalabrutinib vs Rituximab Plus Idelalisib (IdR) or Bendamu..:

Ghia, Paolo ; Pluta, Andrzej ; Wach, Malgorzata...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  - p. S280-S281 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Bevacizumab plus paclitaxel versus placebo plus paclitaxel ..:

Miles, David ; Cameron, David ; Bondarenko, Igor...
European Journal of Cancer.  70 (2017)  - p. 146-155 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Assessment of HER2 testing patterns, HER2+ disease, and the..:

Stenehjem, David ; Yoo, Minkyoung ; Unni, Sudhir...
Breast Cancer: Targets and Therapy.  , 2014
Link: https://doi.org/10.2147/..
 
?
13

Treatment patterns and clinical outcomes for patients with ..:

Yardley, Denise A. ; Kaufman, Peter A. ; Brufsky, Adam...
Breast Cancer Research and Treatment.  145 (2014)  3 - p. 725-734 , 2014
Link: https://doi.org/10.1007/..
 
?
14

First-Line Treatment Patterns and Clinical Outcomes in Pati..:

Tripathy, Debu ; Kaufman, Peter A. ; Brufsky, Adam M....
The Oncologist.  18 (2013)  5 - p. 501-510 , 2013
Link: https://doi.org/10.1634/..
 
?
15

Patient controlled intravenous opioid analgesia versus conv..:

Hudcova, Jana ; McNicol, Ewan ; Quah, Cheng..
Acute Pain.  7 (2005)  3 - p. 115-132 , 2005
Link: https://doi.org/10.1016/..
 
1-15